Timing of birth and risk of multiple sclerosis: population based study

Abstract Objectives To determine if risk of multiple sclerosis (MS) is associated with month of birth in countries in the northern hemisphere and if factors related to month of birth interact with genetic risk. Design Population based study with population and family based controls and a retrospective cohort identified from death certificates. A post hoc pooled analysis was carried out for large northern datasets including Sweden and Denmark. Setting 19 MS clinics in major cities across Canada (Canadian collaborative project on the genetic susceptibility to multiple sclerosis); incident cases of MS from a population based study in the Lothian and Border regions of Scotland; and death records from the UK Registrar General. Populations 17 874 Canadian patients and 11 502 British patients with multiple sclerosis. Main outcome measure Diagnosis of multiple sclerosis. Results In Canada (n = 17 874) significantly fewer patients with MS were born in November compared with controls from the population census and unaffected siblings. These observations were confirmed in a dataset of British patients (n = 11 502), in which there was also an increase in the number of births in May. A pooled analysis of datasets from Canada, Great Britain, Denmark, and Sweden (n = 42 045) showed that significantly fewer (8.5%) people with MS were born in November and significantly more (9.1%) were born in May. For recent incident data, the effect of month of birth was most evident in Scotland, where MS prevalence is the highest. Conclusions Month of birth and risk of MS are associated, more so in familial cases, implying interactions between genes and environment that are related to climate. Such interactions may act during gestation or shortly after birth in individuals born in the northern countries studied.

[1]  N. Risch,et al.  Parent-of-origin effect in multiple sclerosis: observations in half-siblings , 2004, The Lancet.

[2]  A. Mackay-Sim,et al.  Vitamin D3: implications for brain development , 2004 .

[3]  N. Risch,et al.  Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[5]  C. Huerta,et al.  Respiratory medications and risk of asthma death , 2002, Thorax.

[6]  R. Vieth,et al.  Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it , 2001, European Journal of Clinical Nutrition.

[7]  R. Pauwels,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[8]  A. Sadovnick,et al.  Conjugal multiple sclerosis: Population‐based prevalence and recurrence risks in offspring , 2000, Annals of neurology.

[9]  R. Yolken,et al.  Seasonal Birth Patterns of Neurological Disorders , 2000, Neuroepidemiology.

[10]  P. Aridon,et al.  Is season of birth associated with multiple sclerosis? , 2000, Acta neurologica Scandinavica.

[11]  D. English,et al.  The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. , 2000, Brain : a journal of neurology.

[12]  P. Burney,et al.  Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma , 1999, Thorax.

[13]  N. Risch,et al.  Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  P. Rothwell,et al.  High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition , 1998, Journal of neurology, neurosurgery, and psychiatry.

[15]  R. Yolken,et al.  Seasonality of births in schizophrenia and bipolar disorder: a review of the literature , 1997, Schizophrenia Research.

[16]  M. Sears Bronchodilators and acute cardiac death. , 1997, American journal of respiratory and critical care medicine.

[17]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Suissa,et al.  Confounding by indication and channeling over time: the risks of beta 2-agonists. , 1996, American journal of epidemiology.

[19]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[20]  J. Mcleod,et al.  Epidemiology of multiple sclerosis in Australia: With NSW and SA survey results , 1994, The Medical journal of Australia.

[21]  Chung Kf The current debate concerning beta-agonists in asthma: a review. , 1993 .

[22]  J. Morley Asthma mortality and inhaled beta agonist therapy. , 1992, Australian and New Zealand journal of medicine.

[23]  P. Mortensen,et al.  Season of birth in multiple sclerosis , 1992, Acta neurologica Scandinavica.

[24]  J. Fawcett,et al.  Geographic distribution of MS in New Zealand , 1988, Neurology.

[25]  M. Holick,et al.  Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. , 1987, Archives of dermatology.

[26]  G. Dean,et al.  Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[27]  G. Beebe,et al.  Epidemiology of multiple sclerosis in U.S. veterans , 1979, Neurology.

[28]  J. Eaton,et al.  Skin color and nutrient photolysis: an evolutionary hypothesis. , 1978, Science.

[29]  G. Dean,et al.  Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. , 1967, British medical journal.

[30]  E. Acheson,et al.  SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.